QINGFENG Pharma Group, founded in 1976, is an innovation driven and comprehensive pharmaceutical group covering the whole industrial layout including R&D, clinical translation, manufacture and commercialization.
Up to 35 commercialized products with annual sales around 5 billion, we ranked round top 30 pharmaceutical group in China.
Currently we have 2000+ staff, of which 700 + are R&D scientists.
With more than 10% of revenue invested in R&D per year, we have established multiple R&D platforms located in Beijing, Shanghai, Hangzhou and etc., and 60+ pipelines are under development, 35 pipelines to be launched in 2023.
We have two manufacturing plants covering 500,000 m2 with the production capacity of 6.5 billion tablets, 10 billion capsules, 300 million injections, 54 million oral solution, 0.5 billion granules and 5 ton APIs.
Our sales network covers 31 provinces, 2000+ counties, 4000+ towns, 5000+ hospitals, 20,000+ clinics and 60,000+ pharmacies.
With our strong above-mentioned and marketing, IP, regulatory, medical and clinical expertise, resources and experience, we are expanding into global market with the focus on oncology, respiratory, anti-infection and CNS areas.